Skip to content
Home/Companies/Healthcare/KabaFusion

KabaFusion

Healthcare·US·Exited 2026·Held 4yr
Entry
2022
Hold
4yr
Exit
2026

Who owns KabaFusion?

KabaFusion was owned by Novo Holdings through Novo Holdings Principal Investments (1999 vintage) from 2022 to 2026, exited via Secondary.

Buyer identity available on Pro.

Hand-verified · updated 2026-08-18

Novo Holdings
Investor
Novo Holdings
Novo Holdings Principal Investments · 1999 · Buyout

Key facts

HQUnited States
SectorHealthcare
StatusAcquired
Exit Type
Secondary
Buyer
MOIC
–
Exit Year
2026

More from Novo Holdings Principal Investments

Other portfolio companies in the same fund.

Tempus AI
Active
HealthTechUS· 2026
Benchmark Genetics
Active
AgTechUK· 2025
KalVista Pharmaceuticals
Active
PharmaUS· 2025
Schott Poonawalla
Active
IndustrialsIndia· 2025
Catalent
Active
PharmaUS· 2024
Inozyme Pharma
Exited 2025
BiotechUS· 2023
to

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abode Healthcare
Active
Summit PartnersUS
AccentCare
AccentCare
Active
Advent InternationalUS
Acentra Health
Acentra Health
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Track KabaFusion

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy KabaFusion?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on KabaFusion.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue